Blood filter shows promise for severe psoriasis in small trial
NCT ID NCT06640114
First seen Jan 04, 2026 · Last updated May 09, 2026 · Updated 18 times
Summary
This study tested a device called Efferon CT that filters the blood to remove extra immune proteins (cytokines) that drive psoriasis. Sixty adults with moderate-to-severe plaque psoriasis received this treatment alongside their usual therapy. The goal was to see if filtering the blood could improve skin symptoms and quality of life, and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
North-Western State Medical University named after I.I. Mechnikov (NWSMU)
Saint Petersburg, Russia
-
North-Western district scientific and clinical center named after L. G. Sokolov Federal Medical and Biological Agency
Saint Petersburg, 194291, Russia
Conditions
Explore the condition pages connected to this study.